Claravie
- Product NDC
- 61554-309
- 11-digit product format
- 615540309
- Labeler code
- 61554
- Product ID
- 61554-309_597cb2f0-ff06-a1ab-e063-6294a90acda9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin Zinc, Neomycin Sulfate, Polymyxin B
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Gentell LLC
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-08-20
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B
- Active strength
- 400; 5; 5000 U/g; mg/g; U/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Claravie
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 400 U/g |
| NEOMYCIN SULFATE | 5 mg/g |
| POLYMYXIN B | 5000 U/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| J2VZ07J96K | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 204602 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 597cb2f0-ff05-a1ab-e063-6294a90acda9 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Wellness Antiseptic and Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | FRONT PHARMACEUTICAL PLC | cb7fdcde-2bd8-4834-ba4e-4d6fd1512599 | 2023-10-26 | Warnings | M004 |
| GENUINE FIRST AID Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 23abfe12-5b50-4b49-878e-4fcdb6c341fd | 2023-10-19 | Warnings | M004 |
| EVERLIT CARE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | f4921508-c32f-426f-a2f0-16c3acbd4713 | 2023-10-14 | Warnings | M004 |
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | M004 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 61554-309-11 | 61554030911 | 28.3 g in 1 TUBE (61554-309-11) | 28.3 g | 2026-08-20 | No | No | Current |
| 61554-309-21 | 61554030921 | .9 g in 1 PACKET (61554-309-21) | 2026-08-20 | No | No | Current |